[go: up one dir, main page]

FI971277A - IRDS:in ja ARDS:in hoitoon tarkoitettuja koostumuksia, jotka sisältävät ainakin yhtä glukortikosteroidia yhdistelmänä keuhkopinta-aktiivisen aineen kanssa - Google Patents

IRDS:in ja ARDS:in hoitoon tarkoitettuja koostumuksia, jotka sisältävät ainakin yhtä glukortikosteroidia yhdistelmänä keuhkopinta-aktiivisen aineen kanssa Download PDF

Info

Publication number
FI971277A
FI971277A FI971277A FI971277A FI971277A FI 971277 A FI971277 A FI 971277A FI 971277 A FI971277 A FI 971277A FI 971277 A FI971277 A FI 971277A FI 971277 A FI971277 A FI 971277A
Authority
FI
Finland
Prior art keywords
treatment
irds
glucocorticosteroid
ards
combination
Prior art date
Application number
FI971277A
Other languages
English (en)
Swedish (sv)
Other versions
FI118886B (fi
FI971277A0 (fi
Inventor
Paul-Georg Germann
Klaus Eistetter
Ulrich Kilian
Dietrich Haefner
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI971277A0 publication Critical patent/FI971277A0/fi
Publication of FI971277A publication Critical patent/FI971277A/fi
Application granted granted Critical
Publication of FI118886B publication Critical patent/FI118886B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI971277A 1994-09-28 1997-03-26 Keuhkojen pinta-aktiivisuusaineen ja vähintään yhden glukokortikosteroidin yhdistelmän käyttö IRDS:n ja ARDS:n hoitoon tarkoitetun lääkeaineen valmistamiseksi FI118886B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4434629 1994-09-28
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten
EP9503816 1995-09-27

Publications (3)

Publication Number Publication Date
FI971277A0 FI971277A0 (fi) 1997-03-26
FI971277A true FI971277A (fi) 1997-05-27
FI118886B FI118886B (fi) 2008-04-30

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971277A FI118886B (fi) 1994-09-28 1997-03-26 Keuhkojen pinta-aktiivisuusaineen ja vähintään yhden glukokortikosteroidin yhdistelmän käyttö IRDS:n ja ARDS:n hoitoon tarkoitetun lääkeaineen valmistamiseksi

Country Status (26)

Country Link
US (1) US5891844A (fi)
EP (1) EP0783314B1 (fi)
JP (1) JP4425991B2 (fi)
KR (1) KR100365030B1 (fi)
CN (1) CN1100542C (fi)
AT (1) ATE241372T1 (fi)
AU (1) AU705099B2 (fi)
BG (1) BG62556B1 (fi)
CA (1) CA2201377C (fi)
CZ (1) CZ292846B6 (fi)
DE (2) DE4434629C1 (fi)
DK (1) DK0783314T3 (fi)
EE (1) EE03422B1 (fi)
ES (1) ES2201120T3 (fi)
FI (1) FI118886B (fi)
HK (1) HK1003869A1 (fi)
HU (1) HU226958B1 (fi)
MX (1) MX9702303A (fi)
NO (1) NO313405B1 (fi)
NZ (1) NZ294587A (fi)
PL (1) PL187496B1 (fi)
PT (1) PT783314E (fi)
RU (1) RU2157222C2 (fi)
SK (1) SK284446B6 (fi)
UA (1) UA43378C2 (fi)
WO (1) WO1996009831A2 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
ATE336254T1 (de) * 1997-02-17 2006-09-15 Altana Pharma Ag Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
EP1189625A1 (en) * 1999-06-11 2002-03-27 Byk Gulden Lomberg Chemische Fabrik GmbH Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
CA2384861A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
PT1276495E (pt) * 2000-04-12 2006-08-31 Altana Pharma Ag Utilizacao de tensioactivo pulmonar recombinante para o tratamento precoce de doencas pulmonares agudas
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) * 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
CA2529007C (en) 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
JP5618452B2 (ja) * 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
WO2006074296A1 (en) 2005-01-06 2006-07-13 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
WO2012077127A1 (en) * 2010-12-10 2012-06-14 Indian Institute Of Technology, Bombay A protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
RU2757902C2 (ru) * 2016-12-22 2021-10-22 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Терапевтическая комбинация для лечения развивающейся bpd, содержащая легочный сурфактант и стероид

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
CZ94097A3 (en) 1997-09-17
SK40197A3 (en) 1998-02-04
CA2201377A1 (en) 1996-04-04
KR970706006A (ko) 1997-11-03
DK0783314T3 (da) 2003-12-01
CN1100542C (zh) 2003-02-05
AU705099B2 (en) 1999-05-13
US5891844A (en) 1999-04-06
NO313405B1 (no) 2002-09-30
UA43378C2 (uk) 2001-12-17
BG101441A (en) 1997-09-30
NZ294587A (en) 1998-07-28
EE03422B1 (et) 2001-06-15
MX9702303A (es) 1997-06-28
NO971403L (no) 1997-04-17
PL319608A1 (en) 1997-08-18
WO1996009831A2 (de) 1996-04-04
DE4434629C1 (de) 1996-06-27
HU226958B1 (en) 2010-03-29
JP4425991B2 (ja) 2010-03-03
FI118886B (fi) 2008-04-30
CN1163571A (zh) 1997-10-29
DE59510705D1 (de) 2003-07-03
EP0783314B1 (de) 2003-05-28
WO1996009831A3 (de) 1996-05-23
AU3742895A (en) 1996-04-19
NO971403D0 (no) 1997-03-25
JPH10506119A (ja) 1998-06-16
BG62556B1 (bg) 2000-02-29
PT783314E (pt) 2003-10-31
FI971277A0 (fi) 1997-03-26
EP0783314A2 (de) 1997-07-16
ES2201120T3 (es) 2004-03-16
HK1003869A1 (en) 1998-11-13
SK284446B6 (sk) 2005-04-01
RU2157222C2 (ru) 2000-10-10
KR100365030B1 (ko) 2003-03-10
HUT77931A (hu) 1998-11-30
PL187496B1 (pl) 2004-07-30
CA2201377C (en) 2008-07-29
CZ292846B6 (cs) 2003-12-17
ATE241372T1 (de) 2003-06-15
EE9700084A (et) 1997-10-15

Similar Documents

Publication Publication Date Title
FI971277A (fi) IRDS:in ja ARDS:in hoitoon tarkoitettuja koostumuksia, jotka sisältävät ainakin yhtä glukortikosteroidia yhdistelmänä keuhkopinta-aktiivisen aineen kanssa
DE69108142D1 (de) Zusammensetzung zur Verwendung in der Mundhöhle.
FI963468A0 (fi) Menetelmät ja koostumukset insuliinin antamiseksi keuhkojen kautta
FI971806A0 (fi) Valssisto kappaleiden kuljettamiseksi korkeissa lämpötiloissa
KR900007064U (ko) 냉장고의 가습 장치
DE69105845D1 (de) Staubsaugergebläse mit Laufrad.
FI932248A0 (fi) Hepatit B-vaccinkomposition innehaollande ett gallsyrasalt
IT1197424B (it) Perfezionamento nei compressori d'aria
DE69001295D1 (de) In zufuhranlage niederschlaege kontrollierende zusammensetzungen.
MY107976A (en) Improvements in or relating to organic compounds
FI890729A (fi) Anordning foer montering av delarna i en vinkelremledning.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
KR940006077U (ko) 공기청정기능이 구비된 자연증발식 가습기
EP0468327A3 (en) Oral pharmaceutical compositions containing hirudin
ES513692A0 (es) "perfeccionamientos en los sistemas de mantener el contenido de aire en instalaciones de bombeo".
FI914315A0 (fi) Alakattorakenne ja menetelmä ilman virtauttamiseksi alakattorakenteen yhteydessä
ITMI940685V0 (it) Tratto di trasporto con almeno due trasportatori estendentisi trasversalmente l'uno rispetto all'altro
ITMI930098A0 (it) Soffiante in particolare per aspirapolvere
SE9301674D0 (sv) Luftavfuktare, aeven i kombination med frisklufttillfoersel
NO885009D0 (no) Anordning ved luftinntak i respirator.
FI870778A0 (fi) Tank foer transport och/eller lagring av torrmaterial avsett foer anvaendning i betongmassa.
IT1222636B (it) Perfezionamento nei frigoriferi del tipo cosidetto ventilato
IT8224930A0 (it) Composizione detergente e disinfettante ad ossigeno attivo.
IT8348801A0 (it) Composizione battericida volatile polivalente
IT8301002V0 (it) Poltroncina trasformabile in tavolo

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NYCOMED GMBH

Free format text: NYCOMED GMBH

FG Patent granted

Ref document number: 118886

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: TAKEDA GMBH

MM Patent lapsed